| Literature DB >> 20428036 |
Yan-Li Zhao1, Qiu-Xia He, Yang Li, Si-Feng Wang, Ke-Chun Liu, Yong-Ping Yang, Xiao-Li Li.
Abstract
A new kaurane diterpenoid, 3alpha,18-dihydroxy-3beta,20-epoxykaur-15-ene (1), was isolated from the aerial parts of Excoecaria acerifolia (Euphorbiaceae) together with 16 known compounds. Their structures were identified by extensive spectral analysis, especially 2D NMR techniques. Antiangiogenic effects of compounds 1-6 and 9-17 were evaluated using a zebrafish model, with compound 9 being active in this bioassay. At the same time, compounds 4, 6, 10, 11 showed activity in inhibiting the growth of A549 lung cancer cells, and the compound 10 also showed apoptosis-inducing effects on A549 lung cancer cells.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20428036 PMCID: PMC6257216 DOI: 10.3390/molecules15042178
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The structures of compounds 1-17.
The NMR data of 1 (in CDCl3).
| Position | δC | δH | Position | δC | δH |
|---|---|---|---|---|---|
| 1a | 30.2 (t) | 1.18 (m) | 11a | 19.2 (t) | 1.12 (m) |
| 1b | 1.58 (m) | 11b | 1.49 (m) | ||
| 2a | 24.5 (t) | 1.61 (m) | 12a | 34.9 (t) | 1.18 (m) |
| 2b | 1.40 (m) | 12b | 1.58 (m) | ||
| 3 | 98.6 (s) | / | 13 | 42.1 (d) | 2.19 (d, 5.7) |
| 4 | 43.9 (s) | / | 14a | 44.7 (t) | 1.12 (m) |
| 5 | 45.9 (d) | 1.43(m) | 14b | 1.49 (m) | |
| 6a | 20.6 (t) | 1.12 (m) | 15 | 133.3 (d) | 5.04 (s) |
| 6b | 1.49 (m) | 16 | 142.4 (s) | / | |
| 7a | 36.4 (t) | 1.78 (m) | 17 | 15.4 (q) | 1.68 (s) |
| 7b | 1.53 (m) | 18a | 70.2 (t) | 3.66 (d, 11.0) | |
| 8 | 48.2 (s) | / | 18b | 3.30 (d, 11.0) | |
| 9 | 43.8 (d) | 1.46 (m) | 19 | 13.4 (q) | 1.15 (s) |
| 10 | 36.5 (s) | / | 20a | 68.0 (t) | 4.43 (dd, 8.5, 2.0) |
| 20b | 3.86 (dd, 8.5, 2.0) |
a Spectra were obtained at 400 (1H-NMR) and 100 (13C-NMR) MHz in CDCl3 and chemical shifts (δ) are in ppm with J values in Hz.
Anti-angiogenic activity of compounds 1-6, 9-17.
| Compound | Concentration | Intersegmental Vessels (ISV) | Inhibition Ratio (%) |
|---|---|---|---|
|
| 100 | 24.7 ± 1.2 | 8.0 |
|
| 100 | 26.7 ± 1.2 | 0.5 |
|
| 100 | 26.0 ± 0.0 | 3.0 |
|
| 100 | 24.7 ± 1.2 | 8.0 |
|
| 100 | 24.7 ± 1.2 | 8.0 |
|
| 100 | 20.0 ± 2.8 | 25.4 |
|
| 50 | 9.4 ± 8.4 ** | 64.9 |
|
| 100 | 26.7 ± 1.2 | 0.5 |
|
| 100 | 26.7 ± 1.2 | 0.5 |
|
| 100 | 26.3 ± 1.5 | 1.7 |
|
| 100 | 24.7 ± 0.6 | 8.0 |
|
| 100 | 26.3 ± 0.6 | 1.7 |
|
| 100 | 25.0 ± 0.0 | 6.7 |
|
| 100 | 24.7 ± 2.3 | 8.0 |
|
| 100 | 27.0 ± 1.0 | 0 |
| control
| 26.8 ± 1.8 | ||
| PTK787 | 10 | 0 ** | 100 |
0.1% DMSO in sterile salt water; ** means that the value was significantly different from the control and p < 0.01.
Inhibitory effect of compounds 4, 6, 10, 11 on the proliferation of A549 lung cancer cells.
| M(%) a/ Compounds | Concentration | ||
|---|---|---|---|
| 25 μg/mL | 50 μg/mL | 100 μg/mL | |
|
| 12.78 ± 6.56 | 40.8 ± 2.96** | 52.51 ± 2.97** |
|
| 14.35 ± 0.61** | 48.76 ± 5.08** | 62.03 ± 5.72** |
|
| 15.92 ± 3.12** | 61.13 ± 2.49** | 74.6 ± 2.28** |
|
| 22.38 ± 8.37 | 26.47 ± 5.25** | 48.6 ± 6.76** |
a M (%) means the mean value of inhibition ratio, *, p < 0.05, **, p < 0.01, compared with control group.
Figure 3Photos of acridine orange staining (A: compound 10, B: control).